A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality-Reference-Cited by-同舟云学术

A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality

Published:2023-09 Issue:3 Volume:104 Page:542-551
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Faucon Anne-Laure,Fu Edouard L.,Stengel Bénédicte,Mazhar Faizan,Evans Marie,Carrero Juan-Jesús

Publisher

Elsevier BV

Subject

Nephrology

Reference62 articles.

1. Extracellular fluid volume is an independent determinant of uncontrolled and resistant hypertension in chronic kidney disease: a NephroTest cohort study;Vidal-Petiot;J Am Heart Assoc,2018

2. Trajectory of extracellular fluid volume over time and subsequent risks of end-stage kidney disease and mortality in chronic kidney disease: a prospective cohort study;Faucon;J Intern Med,2021

3. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease;Faucon;Kidney Int,2019

4. Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study;Tsai;Am J Kidney Dis,2014

5. Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD;Tsai;Clin J Am Soc Nephrol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting chronic responses to calcium channel blockade with a virtual population of African Americans with hypertensive chronic kidney disease;Frontiers in Systems Biology;2024-07-04

2. Sex and the Risk of Atheromatous and Nonatheromatous Cardiovascular Disease in CKD: Findings From the CKD-REIN Cohort Study;American Journal of Kidney Diseases;2024-06

3. Risk of CKD among patients with DM taking diuretics or SGLT2i: a retrospective cohort study in Taiwan;BMC Pharmacology and Toxicology;2024-03-05

4. Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders—Is There a Breakthrough?;Antioxidants;2023-12-07

5. Initiation of diuretics or calcium channel blockers on the top of renin-angiotensin system inhibitors on kidney outcome: which is better?;Kidney International;2023-11